Shah, J. J., Jakubowiak, A. J., O’Connor, O. A., Orlowski, R. Z., Harvey, R. D., Smith, M. R., . . . Lonial, S. (2015). Phase I Study of the Novel Investigational NEDD8-activating Enzyme Inhibitor Pevonedistat (MLN4924) in Patients with Relapsed/refractory Multiple Myeloma or Lymphoma. Clin Cancer Res.
Chicago Style CitationShah, Jatin J., et al. "Phase I Study of the Novel Investigational NEDD8-activating Enzyme Inhibitor Pevonedistat (MLN4924) in Patients With Relapsed/refractory Multiple Myeloma or Lymphoma." Clin Cancer Res 2015.
MLA CitationShah, Jatin J., et al. "Phase I Study of the Novel Investigational NEDD8-activating Enzyme Inhibitor Pevonedistat (MLN4924) in Patients With Relapsed/refractory Multiple Myeloma or Lymphoma." Clin Cancer Res 2015.